Inicio › Síndromes mielodisplásicos › Misuri
Ensayos clínicos de Síndromes mielodisplásicos en Misuri
15 estudios sobre Síndromes mielodisplásicos buscan participantes en Misuri.
Ciudades en Misuri
Texto oficial del estudio (inglés)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Parkland Health Center - Farmington, Farmington
- Sainte Genevieve County Memorial Hospital, Sainte Genevieve
- Missouri Baptist Medical Center, St Louis
- y 1 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06577441Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- y 2 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06484062MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Parkland Health Center - Farmington, Farmington
- y 10 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Washington University St.Louis, St Louis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT05320198A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- American Oncology Partners P.A. MidAmerica Cancer Care, Kansas City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07422480Collection of Tissue Samples for Cancer Research
- Washington University - St. Louis, St Louis
ReclutandoEstudio observacional
2 Months · Todos los sexos · Actualizado el 16 sept 2026 · NCT00900198The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- University of Missouri Children's Hospital, Columbia
- Children's Mercy Hospitals and Clinics, Kansas City
- Cardinal Glennon Children's Medical Center, St Louis
- y 2 más
ReclutandoFase 1/2
Hasta los 22 · Todos los sexos · Actualizado el 25 ago 2026 · NCT04726241A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- MidAmerica Cancer Care, Kansas City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 ago 2026 · NCT06499285Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
- Washington University, St Louis
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06529731Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
- WashU Medicine, St Louis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT05308264Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
- Washington University School of Medicine, St Louis
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jul 2026 · NCT05483010Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- Washington University School of Medicine, St Louis
ReclutandoFase 1/2
Edades de 18 a 75 · Todos los sexos · Actualizado el 23 mar 2026 · NCT04742634Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
- Washington University School of Medicine, St Louis
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 dic 2025 · NCT05434598SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Kansas City
- Massive Bio SYNERGY-AI site, St Louis
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
- Washington University School of Medicine, St Louis
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2025 · NCT04986657De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.